REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Filed Mar 3, 2016 · 10-K · 63 days after period end · 0001564590-16-013941
| Metric | Q4 2015 | Q4 2014 |
|---|---|---|
| Revenue | $4.44M | $1.15M |
| Net Income | -$5.18M | -$2.33M |
| EPS Diluted | -$0.20 | -$0.97 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 3, 2016 · 63 d after period end
